BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35801241)

  • 1. Identification of Two Subtypes and Prognostic Characteristics of Lung Adenocarcinoma Based on Pentose Phosphate Metabolic Pathway-Related Long Non-coding RNAs.
    Liu C; Wang Y
    Front Public Health; 2022; 10():902445. PubMed ID: 35801241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs.
    Fan Z; Wang Y; Niu R
    Funct Integr Genomics; 2022 Oct; 22(5):919-936. PubMed ID: 35665866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma.
    Wang J; Shu J
    Curr Med Chem; 2024; 31(12):1539-1560. PubMed ID: 37680151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
    Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
    Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes.
    Cao P; Zhao B; Xiao Y; Hu S; Kong K; Han P; Yue J; Deng Y; Zhao Z; Wu D; Zhang L; Li F
    Biomed Res Int; 2022; 2022():7587398. PubMed ID: 35178454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Tumor Immune Microenvironment and Prognosis of m6A-Related IncRNAs in Lung Adenocarcinoma.
    Shen Y; Hou N; Han F; Chen B; Shi J; Sun X
    Crit Rev Eukaryot Gene Expr; 2022; 32(5):77-91. PubMed ID: 35993946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma.
    Wang B; Hou C; Yu X; Liu J; Wang J
    Sci Rep; 2024 Apr; 14(1):8879. PubMed ID: 38632255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer.
    Liu X; Gao J; Wang J; Chu J; You J; Jin Z
    Exp Biol Med (Maywood); 2021 Mar; 246(5):547-559. PubMed ID: 33203236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma.
    Ren J; Wang A; Liu J; Yuan Q
    Bioengineered; 2021 Dec; 12(1):4331-4348. PubMed ID: 34338158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma.
    Salavaty A; Rezvani Z; Najafi A
    J Cell Mol Med; 2019 Aug; 23(8):5600-5617. PubMed ID: 31211495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of subtype classifiers and validation of a prognostic risk model based on hypoxia-associated lncRNAs for lung adenocarcinoma.
    Hui H; Li D; Lin Y; Miao H; Zhang Y; Li H; Qiu F; Jiang B
    J Thorac Dis; 2023 Jul; 15(7):3919-3933. PubMed ID: 37559652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27.
    Qiu M; Xu Y; Wang J; Zhang E; Sun M; Zheng Y; Li M; Xia W; Feng D; Yin R; Xu L
    Cell Death Dis; 2015 Aug; 6(8):e1858. PubMed ID: 26291312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung.
    Miao H; Chen D; Li R; Hu J; Chen Y; Xu C; Wen Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 15. Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma.
    Zhuang J; Chen Z; Chen Z; Chen J; Liu M; Xu X; Liu Y; Yang S; Hu Z; He F
    Respir Res; 2022 May; 23(1):123. PubMed ID: 35562727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of long non-coding RNA‚ÄĎassociated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Subtypes and Identification of Key lncRNAs Based on Glutamine Metabolism-Related Long Noncoding RNAs.
    Feng Y; Sun X; Yang T; Han J; Zhou D; Ren H; Sheng Y; Wang Y
    Comput Math Methods Med; 2022; 2022():2807354. PubMed ID: 35529265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B; Chen Y; Yang J
    Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma.
    Mai S; Liang L; Mai G; Liu X; Diao D; Cai R; Liu L
    Front Endocrinol (Lausanne); 2022; 13():829175. PubMed ID: 35422758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
    Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
    Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.